Solstice Biologics raises $4M – but where did CEO Lou Tartaglia go?
After one year at biotech startup Solstice Biologics, Third Rock vet Lou Tartaglia's back in venture land - having joined 5AM Ventures.
That RNAi startup whose founder was shot by a disgrunted biotech exec just raised $7.5M
Solstice Biologics, an interesting RNAi therapeutics company that has attracted attention for the wrong reasons, has raised $7.5 million, according to a regulatory filing, building on the $18 million raised last year from venBio and Aeris Capital. The San Francisco company is figuring out how to get RNAi-based drugs to cross multiple cell types to treat different […]
presented by
Improving Medical Billing to Cut Payment Bottlenecks
Yusuf Qasim, President of Payments Optimization at Zelis, discussed how the company is transforming healthcare payments from a fragmented, patchwork system into a modern, digital infrastructure.
The lucky ones: Check out Timmerman’s list of biotech startups funded in 2013
Luke Timmerman at Xconomy crunched the biotech funding numbers for this year to compile a class of 2013 list. You won’t be surprised that he found things haven’t been this bad since 1996: There were only 102 first-time financings of life sciences companies through the first nine months of 2013, the lowest amount since 1996, […]